Arthroscopic hip procedures in patients without known hip disease are relatively infrequent and commonly require admission for observation. Clinicians should be aware of the need for observation when deciding the timing of hip arthroscopic interventions in asymptomatic patients.
The authors report a dramatic effect of arthroscopy in treating refractory cases of recalcitrant hip pain in two patients who were almost exclusively osteolytic. In the authors' series, it is possible to show an improvement to or even complete recovery, even in advanced cases. We advocate early referral for arthroscopic treatment to avoid the need to perform conventional surgery.
Hip arthroscopy is performed on a regular basis for an array of conditions. Most procedures involve the removal of a small amount of cartilage. Complications are rare. We found that the type of instrument used ranged from a standard instrument to a proprietary system. The type of system, the number of systems used, and the length of the procedure for hip arthroscopy generally did not affect the length of the stay in the clinic. The use of anesthesia for hip arthroscopy was more common than previous reports had shown. The use of a specific anesthesia-based system was less common than in the past. Some hospitals use sedation for hip arthroscopy.
We found an increase in the use of hip arthroscopy from 1991 to 1999, as well as the percentage of patients receiving surgery for hip osteoarthritis. In order to ensure equitable access to hip arthroscopy, health delivery systems need to consider these current trends, because our findings suggest that surgeons treat more patients with conditions requiring hip arthroscopy than those in their practice in the past.
Arthroscopy can be performed for a variety of indications including hip problems. However, it typically has a low success rate in treating these problems and a high likelihood of complication.
It is a relatively safe, minimally invasive procedure that can be performed by arthroscopically guided cannulated or percutaneous passage. We report the successful use of hip arthroscopy for osteoarticular pathology in a large series of pediatric and adult hip arthroplasty patients.
Patients who have a primary diagnosis of degenerative disease can be counseled regarding the potential benefits and risks of clinical trials, and are the most likely to enroll and complete clinical trials. Those who have additional coexisting risk factors, however, may be inappropriate for clinical trials and would likely be unwilling to take part.
The number of treatment methods used by patients for either osteoarthritis or hip arthroscopy was high. Most treatments are used in combination with other treatments for patients who have co-morbid conditions including hypertension, diabetes, hypercholesterolaemia, chronic obstructive pulmonary disease, depression, and rheumatoid arthritis. In a recent study, findings might explain why the cost of joint arthroscopy was the highest compared with the other joint treatments.
The risk of complications and mortality after hip resurfacing remain low in the long term. At our centre up to 2.3% of cases have failed, necessitating further THA surgery. These complications pose little risk to quality of life among patients, and so the need for a further joint replacement after THA does not appear to be justified. As a result, hip resurfacing is an attractive option for patients, especially younger patients who can expect a greater and more immediate benefit and more cosmetic outcome.
The side effects of treatment in hip arthroplasty are rare and mild if treated properly. The most common side effect is [infection] of the surgical wound which may be treated with antibiotics. There have been very few serious side effects. If treatment does not have [effect on you], you should probably go home and rest. If the problem persists or becomes worse, see your doctor again. The doctor will ask you a few questions and may recommend [treatment of more drugs or more surgeries] in order to resolve the problem.
The most common cause of hip arthroscopy was femoroacetabular impingement. The incidence of other causes was too low for us to identify any specific indications for hip arthroscopy.
About 13% of individuals under 65 years old with chronic noninfectious pain in the lower extremities undergo hip arthroscopy. An age of between 65 and 94 years old should trigger a high clinical suspicion of chondromalacia patellae. This article is protected by copyright. All rights reserved.